Diffuse large B-cell lymphoma の再発時に合併し, rituximab 治療が奏効した赤芽球癆 Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma

この論文にアクセスする

この論文をさがす

著者

抄録

Malignant lymphoma is often accompanied by an autoimmune disorder. Here, we describe a 82-year-old woman with pure red cell aplasia (PRCA) complicated with relapsed diffuse large B-cell lymphoma. Primary treatment involving chemotherapy, continuous oral administration of prednisolone and a single infusion of rituximab was unsuccessful for both diseases, but the following treatments with 3 courses of rituximab alone for once a week dramatically improved the PRCA as well as the lymphoma. As PRCA complicated with lymphoma is rare, the ideal therapeutic strategy has not yet been established for it. Rituximab may be a good alternative for treating such cases.

収録刊行物

  • 臨床血液 = The Japanese Journal of Clinical Hematology  

    臨床血液 = The Japanese Journal of Clinical Hematology 48(1), 67-70, 2007-01-30 

    The Japanese Society of Hematology

参考文献:  6件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

被引用文献:  1件

被引用文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10018493128
  • NII書誌ID(NCID)
    AN00252940
  • 本文言語コード
    JPN
  • 資料種別
    SHO
  • ISSN
    04851439
  • NDL 記事登録ID
    8616828
  • NDL 雑誌分類
    ZS21(科学技術--医学--内科学)
  • NDL 請求記号
    Z19-295
  • データ提供元
    CJP書誌  CJP引用  NDL  J-STAGE 
ページトップへ